If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 131 - 140 of 275
Anticoagulation in Intracerebral Hemorrhage Survivors for Stroke Prevention and Recovery
Objective
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)
Protocol No
NEURO-NINDS-ASPIRE
Categories
Statin Use in Intracerebral Hemorrhage Patients
Objective
Statins In Intracerbral Hemorrhage (SATURN)
Protocol No
NEURO-NINDS-SATURN
Categories
A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study, Comparing the Efficacy and Safety of Remibrutinib 100mg B.I.D. Versus Teriflunomide 14mg Q.D. in Participants with Relapsing Multiple Sclerosis, Followed by Extended Treatment with Open-
Objective
Remibrutinib vs Teriflunomide in Relapsing MS
Protocol No
NEURO-NOVARTIS-LOU064
A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament
Objective
Current Therapy vs Transition to Ofatumumab After NfL Elevation (SOSTOS)
Protocol No
NEURO-NOVARTIS-SOSTOS
Parkinson's Foundation PD GENEration Genetic Registry
Objective
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab as Monotherapy or in Addition to Baseline Therapy in Patients with Myelin Oligodendr
Objective
Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid)
Protocol No
NEURO-ROCHE-METEOROID
A Randomized, Double-Blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants with Nonrelapsing Secondary Progressive Multiple Sclerosis
Objective
Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Nonrelapsing Secondary Progressive MS
Protocol No
NEURO-SANOFI-EFC17504
Master Protocol of Two Independent, Randomized, Double-Blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants with Relapsing Forms of Multiple Sclerosis
Objective
Master Protocol for SAR441344 to Teriflunomide in Relapsing MS
Protocol No
NEURO-SANOFI-EFC17919
A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke
Objective
Scp776 in Acute Ischemic Stroke
Protocol No
NEURO-SILVERCREEK-ARPEGGIO
Categories
Traumatic Incomplete Tetraplegia without Instability: A Prospective Multicenter Feasibility Study of Outcomes and Prognosis
Objective
Traumatic Incomplete Tetraplegia without Instability
Protocol No
NSUR-AOSPINE-IN-TWIN